Precision System Science Co., Ltd. (TYO:7707)
204.00
-2.00 (-0.97%)
Sep 11, 2026, 3:30 PM JST
Precision System Science Revenue
In the fiscal year ending June 30, 2026, Precision System Science had annual revenue of 5.22B JPY with 11.17% growth. Precision System Science had revenue of 1.44B in the quarter ending June 30, 2026, with 16.91% growth.
Revenue
5.22B
Revenue Growth
+11.17%
P/S Ratio
1.07
Revenue / Employee
34.54M
Employees
151
Market Cap
5.60B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 5.22B | 524.00M | 11.17% |
| Jun 30, 2025 | 4.69B | 713.00M | 17.92% |
| Jun 30, 2024 | 3.98B | -1.30B | -24.61% |
| Jun 30, 2023 | 5.28B | -2.16B | -29.00% |
| Jun 30, 2022 | 7.43B | -1.86B | -20.05% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.62T |
| Otsuka Holdings | 2.62T |
| Chugai Pharmaceutical | 1.34T |
| HOYA Corporation | 983.64B |
| Pharmarise Holdings | 69.51B |
| Care Twentyone | 49.35B |
| LEOCLAN | 40.46B |
| Nippon Chemiphar | 33.02B |